Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
rituximab (rituxan) (2 trials)
zstk-474 (2 trials)
Autoimmune Diseases (Phase 3)
Collagen Diseases (Phase 3)
Neoplasms (Phase 1)
Polyradiculoneuropathy (Phase 2)
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (Phase 2)
Scleroderma, Diffuse (Phase 3)
Scleroderma, Systemic (Phase 3)
Sclerosis (Phase 3)
Trials (4 total)
Trial APIs (2 total)